Market News AIOpen the app

OCUL stock news · Ocular Therapeutix, Inc.

Stories about Ocular Therapeutix, Inc. (OCUL) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for OCUL

Follow Ocular Therapeutix, Inc. (OCUL) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for OCUL
Free on the App Store and Google Play, or on the web.
  1. Oct 16, 2026, 4:22 PM ET · Market

    Ocular Therapeutix, Inc. announced that some directors and officers are leaving, while new ones are being chosen.

    Neutral

    Ocular Therapeutix said its chief strategy officer is leaving to lead a private company. The filing names no replacement or change to Ocular's plans, so it does not show a changed outlook.

  2. Aug 17, 2026, 1:57 PM ET · Market

    Ocular Therapeutix shares rise on Monday amid EyePoint's trial setbacks.

    Good for OCUL

    Ocular Therapeutix's stock is gaining traction following EyePoint's disappointing trial results for its wet AMD treatment, which may enhance Ocular's competitive position as it prepares for its own NDA submission. This situation highlights the shifting dynamics in the wet AMD treatment landscape.